Purpose
to evaluate the safety of the Cerus Corporation’s Intercept Platform’s ability to inactivate the Ebola virus in human plasma
Grantee
Division
Global Development
Date
JANUARY 2015
Region served
GLOBAL
Committed amount
$94,611
Grant topic
Emergency Response
Duration (months)
18
Grantee location
Atlanta, Georgia, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.